Autodisplay:: Development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains

被引:33
作者
Kramer, U
Rizos, K
Apfel, H
Autenrieth, IB
Lattemann, CT
机构
[1] Univ Tubingen, Inst Med Mikrobiol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Krankenhaushyg, D-72076 Tubingen, Germany
[3] CREATOGEN AG, D-86156 Augsburg, Germany
关键词
D O I
10.1128/IAI.71.4.1944-1952.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To optimize antigen delivery by Salmonella vaccine strains, a system for surface display of antigenic determinants was established by using the autotransporter secretion pathway of gram-negative bacteria. A modular system for surface display allowed effective targeting of heterologous antigens or fragments thereof to the bacterial surface by the autotransporter domain of AIDA-I, the Escherichia coli adhesin involved in diffuse adherence. A major histocompatibility complex class II-restricted epitope, comprising amino acids 74 to 86 of the Yersinia enterocolitica heat shock protein Hsp60 (Hsp6074-ab), was fused to the AIDA-I autotransporter domain, and the resulting fusion protein was expressed at high levels on the cell surface of E. coli and Salmonella enterica serovar Typhimurium. Colonization studies in mice vaccinated with Salmonella strains expressing AIDA-I fusion proteins demonstrated high genetic stability of the generated vaccine strain in vivo. Furthermore, a pronounced T-cell response against Yersinia Hsp60(74-86) was induced in mice vaccinated with a Salmonella vaccine strain expressing the Hsp60(74-86)-AIDA-I fusion protein. This was shown by monitoring Yersinia Hsp60-stimulated IFN-gamma secretion and proliferation of splenic T cells isolated from vaccinated mice. These results demonstrate that the surface display of antigenic determinants by the autotransporter pathway deserves special attention regarding the application in live attenuated Salmonella vaccine strains.
引用
收藏
页码:1944 / 1952
页数:9
相关论文
共 46 条
[1]   CLONING AND EXPRESSION OF AN ADHESIN (AIDA-I) INVOLVED IN DIFFUSE ADHERENCE OF ENTEROPATHOGENIC ESCHERICHIA-COLI [J].
BENZ, I ;
SCHMIDT, MA .
INFECTION AND IMMUNITY, 1989, 57 (05) :1506-1511
[2]   VERSATILITY OF A VECTOR FOR EXPRESSING FOREIGN POLYPEPTIDES AT THE SURFACE OF GRAM-NEGATIVE BACTERIA [J].
CHARBIT, A ;
MOLLA, A ;
SAURIN, W ;
HOFNUNG, M .
GENE, 1988, 70 (01) :181-189
[3]   USE OF THE NIRB PROMOTER TO DIRECT THE STABLE EXPRESSION OF HETEROLOGOUS ANTIGENS IN SALMONELLA ORAL VACCINE STRAINS - DEVELOPMENT OF A SINGLE-DOSE ORAL TETANUS VACCINE [J].
CHATFIELD, SN ;
CHARLES, IG ;
MAKOFF, AJ ;
OXER, MD ;
DOUGAN, G ;
PICKARD, D ;
SLATER, D ;
FAIRWEATHER, NF .
BIO-TECHNOLOGY, 1992, 10 (08) :888-892
[4]   Functional mapping of protective domains and epitopes in the rotavirus VP6 protein [J].
Choi, AHC ;
Basu, M ;
McNeal, MM ;
Flint, J ;
VanCott, JL ;
Clements, JD ;
Ward, RL .
JOURNAL OF VIROLOGY, 2000, 74 (24) :11574-11580
[5]   Expressing genes in different Escherichia coli compartments [J].
Cornelis, P .
CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (05) :450-454
[6]   RECOMBINANT AVIRULENT SALMONELLA VACCINE STRAINS WITH STABLE MAINTENANCE AND HIGH-LEVEL EXPRESSION OF CLONED GENES INVIVO [J].
CURTISS, R ;
NAKAYAMA, K ;
KELLY, SM .
IMMUNOLOGICAL INVESTIGATIONS, 1989, 18 (1-4) :583-596
[7]   Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains [J].
De Almeida, MES ;
Newton, SM ;
Ferreira, LCS .
ARCHIVES OF MICROBIOLOGY, 1999, 172 (02) :102-108
[8]   Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen [J].
Dunstan, SJ ;
Simmons, CP ;
Strugnell, RA .
INFECTION AND IMMUNITY, 1998, 66 (02) :732-740
[9]   Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses [J].
Ermak, TH ;
Giannasca, PJ ;
Nichols, R ;
Myers, GA ;
Nedrud, J ;
Weltzin, R ;
Lee, CK ;
Kleanthous, H ;
Monath, TP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2277-2288
[10]  
Galen JE, 1999, INFECT IMMUN, V67, P6424